WO2026053138 - NOVEL LIPID AND LIPID NANOPARTICLE FORMULATIONS
National phase entry is expected:
Publication Number
WO/2026/053138
Publication Date
12.03.2026
International Application No.
PCT/IB2025/058905
International Filing Date
04.09.2025
Title **
[English]
NOVEL LIPID AND LIPID NANOPARTICLE FORMULATIONS
[French]
NOUVELLES FORMULATIONS À BASE DE LIPIDES ET DE NANOPARTICULES LIPIDIQUES
Applicants **
HELEX INC.
Inventors
DHONDI, Naveen Kumar
NISHTALA, Anirudhha
CHAUDHURI, Poulami
Priority Data
202441066804
04.09.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2365 | |
| EPO | Filing, Examination, Granting | 9422 | |
| Japan | Filing, Examination, Granting | 2178 | |
| South Korea | Filing, Examination, Granting | 2043 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,748
Contact Us
Abstract[English]
The present invention is in the field of drug delivery and relates to relates to novel cationic lipids that can be used alone or in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles with oligonucleotides, to facilitate the targeted intracellular delivery of therapeutic nucleic acids.[French]
La présente invention concerne le domaine de l'administration de médicaments et concerne de nouveaux lipides cationiques qui peuvent être utilisés seuls ou en combinaison avec d'autres composants lipidiques, tels que des lipides neutres, du cholestérol et des lipides conjugués polymères, pour former des nanoparticules lipidiques avec des oligonucléotides, pour faciliter l'administration intracellulaire ciblée d'acides nucléiques thérapeutiques.